https://www.taxtmi.com/caselaws?id=2954 Recombinant hepatitis-B surface antigen bulk and the corresponding vaccine products were treated as vaccines and similar products under Heading 30.02 because their essential character lay in inducing antibodies and conferring immunity; Heading 35.04 applied only to protein substances not elsewhere specified, so classification favoured the assessee. For valuation, Rule 8 of the Customs Valuation Rules could not be used to adopt the domestic selling price of comparable Indian goods, because the scheme required acceptance of the manufacturing cost plus profit method under Rule 7A. The impugned orders were therefore set aside, and the demand and penalties did not survive. en-us Mon, 01 Oct 2007 00:00:00 +0530 Wed, 16 Apr 2008 11:37:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=2954 Recombinant hepatitis-B surface antigen bulk and the corresponding vaccine products were treated as vaccines and similar products under Heading 30.02 because their essential character lay in inducing antibodies and conferring immunity; Heading 35.04 applied only to protein substances not elsewhere specified, so classification favoured the assessee. For valuation, Rule 8 of the Customs Valuation Rules could not be used to adopt the domestic selling price of comparable Indian goods, because the scheme required acceptance of the manufacturing cost plus profit method under Rule 7A. The impugned orders were therefore set aside, and the demand and penalties did not survive. Case-Laws Central Excise Mon, 01 Oct 2007 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=2954